Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Boston Biochem
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
25.0%
-1.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Cayman Chemical
Competitor Displacement Rate
30.0%
Competitors are displacing Boston Biochem in 30.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Cayman Chemical offers a more extensive range of biochemicals and antibodies, coupled with a stronger online presence and customer support. Boston Biochem appears to lag in product breadth and technical documentation.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[caymanchem.com][biotech-careers.org]⚠️ Identified Vulnerability:Product Breadth
Primary Threat Identified:Cayman Chemical
Target Persona:Biotechnology Scientists
🚨 Threat Velocity:5/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)